BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21086640)

  • 1. [Prognistic value of a study of the expression of argyrophilic nucleolar organizer region associated proteins in case of papillary thyroid cancer].
    Raĭkhlin NT; Bukaeva IA; Smirnova EA; Pavlovskaia AI; Brzhezovskiĭ VZh; Bogatyrev VN; Ponomareva MV
    Arkh Patol; 2010; 72(4):49-52. PubMed ID: 21086640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
    J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
    Liu C; Chen X; Gao Z; Liu Z; Tao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin].
    Tao XF; Liu C; Bai Y; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.
    Sung TY; Kim M; Kim TY; Kim WG; Park Y; Song DE; Park SY; Kwon H; Choi YM; Jang EK; Jeon MJ; Shong YK; Hong SJ; Kim WB
    Thyroid; 2015 Sep; 25(9):1020-5. PubMed ID: 26148673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
    Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
    Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
    Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
    Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
    Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
    Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
    Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
    Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    Brennan K; Holsinger C; Dosiou C; Sunwoo JB; Akatsu H; Haile R; Gevaert O
    BMC Cancer; 2016 Sep; 16(1):736. PubMed ID: 27633254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
    Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
    World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
    Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
    Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer].
    Raĭkhlin NT; Bukaeva IA; Smirnova EA; Gurevich LE; Delektorskaia VV; Polotskiĭ BE; Laktionov KK; Ardzinba Ms
    Arkh Patol; 2008; 70(3):15-8. PubMed ID: 18727426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma.
    Liu TR; Su X; Qiu WS; Chen WC; Men QQ; Zou L; Li ZQ; Fu XY; Yang AK
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3582-91. PubMed ID: 27649658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DLL4 expression in papillary thyroid cancer.
    Zhang YZ; Qin F; Han ZG; Liu Q; Zhou L; Wang YW
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2901-5. PubMed ID: 26241546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.